188 related articles for article (PubMed ID: 38654110)
1. Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid.
van der Sluis K; van Sandick JW; Vollebergh MA; van Dieren JM; Hugen N; Hartemink KJ; Veenhof AAFA; Verhoeven E; van den Berg JG; Snaebjornsson P; Noe M; van Wezel T; Boelens MC; Kodach LL
Oncogene; 2024 Jun; 43(24):1877-1882. PubMed ID: 38654110
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
3. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
4. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid.
Van't Erve I; Rovers KP; Constantinides A; Bolhuis K; Wassenaar EC; Lurvink RJ; Huysentruyt CJ; Snaebjornsson P; Boerma D; van den Broek D; Buffart TE; Lahaye MJ; Aalbers AG; Kok NF; Meijer GA; Punt CJ; Kranenburg O; de Hingh IH; Fijneman RJ
J Pathol Clin Res; 2021 May; 7(3):203-208. PubMed ID: 33635598
[TBL] [Abstract][Full Text] [Related]
5. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer Cells in Peritoneal Lavage Fluid: A Systematic Review Comparing Cytological with Molecular Detection for Diagnosis of Peritoneal Metastases and Prediction of Peritoneal Recurrences.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Valabrega S; Balducci G; Cavallini M
Anticancer Res; 2018 Mar; 38(3):1255-1262. PubMed ID: 29491048
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient.
Zhou S; Xu B; Qi L; Zhu D; Liu B; Wei J
Cancer Biol Ther; 2019; 20(1):15-20. PubMed ID: 30118648
[TBL] [Abstract][Full Text] [Related]
9. Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer.
Yukawa N; Yamada T; Aoyama T; Woo T; Ueda K; Mastuda A; Hara K; Kazama K; Tamagawa H; Sato T; Oshima T; Suzuki A; Aburatani H; Ishikawa S; Saito A; Masuda M; Yoshida H; Rino Y
Anticancer Res; 2023 May; 43(5):2069-2076. PubMed ID: 37097663
[TBL] [Abstract][Full Text] [Related]
10. Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients.
Gęca K; Rawicz-Pruszyński K; Mielko J; Mlak R; Sędłak K; Polkowski WP
Cells; 2020 Sep; 9(10):. PubMed ID: 32992913
[TBL] [Abstract][Full Text] [Related]
11. Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.
Sugita Y; Fujiwara Y; Taniguchi H; Mori T; Ishii T; Niwa H; Okada Y; Takiguchi S; Yasuda T; Yano M; Monden M
Int J Oncol; 2003 Nov; 23(5):1419-23. PubMed ID: 14532985
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer.
Kung CY; Fang WL; Hung YP; Huang KH; Chen MH; Chao Y; Lin SC; Li AF; Lo SS; Wu CW
Aging (Albany NY); 2023 Feb; 15(3):777-790. PubMed ID: 36779847
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study: A prospective diagnostic study.
Yuan Z; Chen W; Liu D; Qin Q; Grady WM; Fichera A; Wang H; Hou T; Lv X; Li C; Wang H; Cai J
Clin Epigenetics; 2023 Apr; 15(1):65. PubMed ID: 37072801
[TBL] [Abstract][Full Text] [Related]
14. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Fristrup C; Kristensen TK; Larsen TR; Pfeiffer P; Mortensen MB; Detlefsen S
J Clin Pathol; 2019 May; 72(5):368-372. PubMed ID: 30755498
[TBL] [Abstract][Full Text] [Related]
15. Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Roussel-Simonin C; Blanc-Durand F; Tang R; Vasseur D; Le Formal A; Chardin L; Yaniz E; Gouy S; Maulard A; Scherier S; Sanson C; Lacroix L; Cotteret S; Mauny L; Zaccarini F; Rouleau E; Leary A
Mol Cancer; 2023 Nov; 22(1):178. PubMed ID: 37932736
[TBL] [Abstract][Full Text] [Related]
16. Analysis Of Risk Factors Of Positive Peritoneal Cytology In Patients Treated For Gastric Cancer--Preliminary Report.
Lisiecki R; Spychała A; Pater K; Murawa D
Pol Przegl Chir; 2015 Oct; 87(10):506-12. PubMed ID: 26812751
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of peritoneal washing cytology in patients with gastric cancer.
Lee SD; Ryu KW; Eom BW; Lee JH; Kook MC; Kim YW
Br J Surg; 2012 Mar; 99(3):397-403. PubMed ID: 22101572
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival.
Baumgartner JM; Raymond VM; Lanman RB; Tran L; Kelly KJ; Lowy AM; Kurzrock R
Ann Surg Oncol; 2018 Aug; 25(8):2400-2408. PubMed ID: 29948422
[TBL] [Abstract][Full Text] [Related]
19. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of peritoneal lavage cytology in gastric cancer].
de Manzoni G; Di Leo A; Tomezzoli A; Pedrazzani C; Piubello Q; Bonfiglio M; Valloncini E; Veraldi GF
Chir Ital; 2002; 54(1):1-6. PubMed ID: 11941998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
